Bayer: A history
By GMWatch,
GMWatch
| 04. 19. 2022
How a chemical and pharmaceutical giant with an appalling record of corporate crimes became a key player in the development, commercialization and sale of GM crops
Bayer AG is a chemical and pharmaceutical giant founded in Barmen, Germany in 1863 by Friedrich Bayer and his partner, Johann Friedrich Weskott. Today it has its headquarters in Leverkusen, North Rhine-Westphalia, Germany.
The merger between Bayer and Monsanto in June of 2018 led many commentators to say the German firm had sullied its reputation by taking over a company consistently shown in polls to be among the most hated in America. But Bayer's own corporate record also bears little scrutiny.
A look at the company's history may, in fact, help to explain how Bayer thought it could take over a firm up to its neck in controversies and court cases and just rebrand Monsanto's products as its own and rake in the profits. After all, as we shall see, for more than a century Bayer has been walking away from corporate crimes from which it has successfully profited.
The product that Bayer is perhaps most famous for is aspirin, which it trademarked in 1899. Bayer's official history has credited Felix Hoffmann with its invention in 1897. But according to Arthur Eichengrün, another chemist employed by Bayer at the time, he... see more
Related Articles
By Casey Crownhart, MIT Technology Review | 06.14.2022
Syrian hamster, by John Stockla,
CC BY-SA 4.0, via Wikimedia Commons
The high-profile debates over gene editing, especially with Crispr-Cas9, mostly focus on its use for humans, whether as gene therapy or heritable modification. Proponents routinely stress that applications must reflect “broad societal consensus” and resolution of “the relevant safety and efficacy issues,” as spelled out in the report on the 2015 [First] International Summit on Human Gene Editing. Meanwhile, experiments on animals continue apace, and some of...
By Jonathan Grinstein, Neo.Life | 05.19.2022
The real-life creation of human-animal hybrids, which is on the verge of going from hypothesis to reality, has been the subject of ongoing debate since the dawn of genetic engineering. But recent advances have made these creatures of dreams (or...
By Antonio Regalado, MIT Technology Review | 05.04.2022
The pig heart transplanted into an American patient earlier this year in a landmark operation carried a porcine virus that may have derailed the experiment and contributed to his death two months later, say transplant specialists.
David Bennett Sr. was...
